$CRIS Headlines Insiders are bullish on these
Post# of 44860
Posted On: 01/26/2015 11:50:19 AM
$CRIS Headlines
Insiders are bullish on these stocks 10:14 a.m. Dec. 11, 2012 - Insider Monkey
FDA approves Roche-Curis drug to treat skin cancer 1:10 p.m. Jan. 30, 2012 - MarketWatch.com
Drug stocks climb; Siga sinks on contract woes 2:53 p.m. June 14, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 2:47 p.m. April 29, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 9:01 a.m. April 29, 2011 - Val Brickates Kennedy
Wednesday’s biggest advancers and decliners 3:35 p.m. April 6, 2011 - Kate Gibson
Optimer, Curis, Orchid in drug-sector spotlight 3:33 p.m. April 6, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 2:34 p.m. March 21, 2011 - Kate Gibson
Curis leads advance for drug stocks 1:38 p.m. March 21, 2011 - Val Brickates Kennedy
Curis soars on skin cancer trial 8:02 a.m. March 21, 2011 - Val Brickates Kennedy
The best biotech stocks to own now 12:01 a.m. Jan. 13, 2011 - Michael Shulman
Monday's biggest gaining and declining stocks 5:16 p.m. Aug. 9, 2010 - MarketWatch
Wednesday's biggest gaining and declining stocks 3:54 p.m. June 16, 2010 - MarketWatch
Friday's biggest gaining and declining stocks 2:53 p.m. Jan. 22, 2010 - MarketWatch
Drug stocks mixed; Curis and Achillion tumble 11:17 a.m. Jan. 22, 2010 - Val Brickates Kennedy
BEFORE THE BELL -2: US HOT STOCKS TO WATCH 7:54 a.m. Sept. 3, 2009 - Dow Jones
Schering-Plough, Merck slide on Vytorin woes 12:46 p.m. Dec. 12, 2007 - Val Brickates Kennedy
Drugs stocks post modest losses 9:03 a.m. Sept. 25, 2007 - William Spain
Drug, biotech stocks trade broadly lower; Dendreon plunges 1:22 p.m. May 9, 2007 - Carolyn Pritchard
Drug stocks mixed, Dynavax rockets on allergy study 3:40 p.m. Oct. 5, 2006 - Val Brickates Kennedy
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More 4:00 p.m. Jan. 23, 2015 - Seeking Alpha
3 Attractive Biotech Picks For 2015 9:44 a.m. Jan. 23, 2015 - Seeking Alpha
Curis (CRIS) in Focus: Stock Adds 17.5% in Session - Tale of the Tape 8:51 a.m. Jan. 23, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
Curis teams up with Aurigene in cancer 7:50 a.m. Jan. 21, 2015 - Seeking Alpha
Curis (CRIS) Surges: Stock Moves 11.9% Higher - Tale of the Tape 9:11 a.m. Dec. 31, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Curis' (CRIS) CEO, Ali Fattaey on Q3 2014 Results - Earnings Call Transcript 1:58 p.m. Nov. 10, 2014 - Seeking Alpha
Curis (CRIS) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 10, 2014 - Seeking Alpha
10-Q: CURIS INC 8:49 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Following Biotech Stocks After Price Declines Of Greater Than 50% 3:03 p.m. Sept. 25, 2014 - Seeking Alpha
Three Biotechs Ready to Partner Up 9:30 a.m. Sept. 8, 2014 - Barrons.com
Genomic Health Raised to Buy on Better-than-Expected Q2 - Analyst Blog 11:10 a.m. Aug. 14, 2014 - Zacks.com
Emergent BioSolutions Misses on Earnings, Ups Revenue View - Analyst Blog 8:50 a.m. Aug. 11, 2014 - Zacks.com
Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session - Tale of the Tape 8:39 a.m. Aug. 11, 2014 - Zacks.com
Genomic Health Q2 Loss Narrower than Expected, Shares Up - Analyst Blog 8:20 a.m. Aug. 11, 2014 - Zacks.com
Medivation (MDVN) Jumps: Stock Adds 7.5% in Session - Tale of the Tape 7:51 a.m. Aug. 11, 2014 - Zacks.com
10-Q: CURIS INC 2:09 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog 11:00 a.m. Aug. 7, 2014 - Zacks.com
Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog 10:32 a.m. Aug. 7, 2014 - Zacks.com
Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets 6:05 a.m. Jan. 21, 2015 - GlobeNewswire
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:04 a.m. Jan. 13, 2015 - Marketwired
Curis Announces Dosing of First Patient in Phase 1 Trial of CUDC-907 in Patients With Advanced/ Relapsed Solid Tumors 7:02 a.m. Dec. 18, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Curis to Present at Upcoming Investor Conferences 7:01 a.m. Nov. 26, 2014 - GlobeNewswire
Curis to Present at the Stifel 2014 Healthcare Conference 7:01 a.m. Nov. 12, 2014 - GlobeNewswire
Titan Pharmaceuticals Appoints Two New Board Members 7:01 a.m. Nov. 11, 2014 - Marketwired
Curis Reports Third Quarter 2014 Financial Results and Pipeline Update 7:02 a.m. Nov. 10, 2014 - GlobeNewswire
Curis to Release Third Quarter 2014 Financial Results and Hold Conference Call on November 10, 2014 7:01 a.m. Nov. 3, 2014 - GlobeNewswire
Curis Announces Allowance of U.S. Patent Covering Compounds Targeting HDAC and PI3K Activities in a Single Molecule 6:02 a.m. Oct. 28, 2014 - GlobeNewswire
Curis to Present at the 13th Annual BIO Investor Forum 6:01 a.m. Oct. 3, 2014 - GlobeNewswire
Curis Announces CUDC-907 Development Program Advancements 6:01 a.m. Oct. 2, 2014 - GlobeNewswire
Curis to Present at Upcoming Investor Conferences 6:00 a.m. Aug. 27, 2014 - GlobeNewswire
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics 8:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Curis Reports Second Quarter 2014 Financial Results 6:01 a.m. Aug. 7, 2014 - GlobeNewswire
Curis to Release Second Quarter 2014 Financial Results and Hold Conference Call on August 7, 2014 6:02 a.m. July 31, 2014 - GlobeNewswire
Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin 7:10 a.m. July 17, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis 6:01 a.m. June 23, 2014 - GlobeNewswire
Curis to Present at the JMP Securities Healthcare Conference 6:01 a.m. June 18, 2014 - GlobeNewswire
Insiders are bullish on these stocks 10:14 a.m. Dec. 11, 2012 - Insider Monkey
FDA approves Roche-Curis drug to treat skin cancer 1:10 p.m. Jan. 30, 2012 - MarketWatch.com
Drug stocks climb; Siga sinks on contract woes 2:53 p.m. June 14, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 2:47 p.m. April 29, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 9:01 a.m. April 29, 2011 - Val Brickates Kennedy
Wednesday’s biggest advancers and decliners 3:35 p.m. April 6, 2011 - Kate Gibson
Optimer, Curis, Orchid in drug-sector spotlight 3:33 p.m. April 6, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 2:34 p.m. March 21, 2011 - Kate Gibson
Curis leads advance for drug stocks 1:38 p.m. March 21, 2011 - Val Brickates Kennedy
Curis soars on skin cancer trial 8:02 a.m. March 21, 2011 - Val Brickates Kennedy
The best biotech stocks to own now 12:01 a.m. Jan. 13, 2011 - Michael Shulman
Monday's biggest gaining and declining stocks 5:16 p.m. Aug. 9, 2010 - MarketWatch
Wednesday's biggest gaining and declining stocks 3:54 p.m. June 16, 2010 - MarketWatch
Friday's biggest gaining and declining stocks 2:53 p.m. Jan. 22, 2010 - MarketWatch
Drug stocks mixed; Curis and Achillion tumble 11:17 a.m. Jan. 22, 2010 - Val Brickates Kennedy
BEFORE THE BELL -2: US HOT STOCKS TO WATCH 7:54 a.m. Sept. 3, 2009 - Dow Jones
Schering-Plough, Merck slide on Vytorin woes 12:46 p.m. Dec. 12, 2007 - Val Brickates Kennedy
Drugs stocks post modest losses 9:03 a.m. Sept. 25, 2007 - William Spain
Drug, biotech stocks trade broadly lower; Dendreon plunges 1:22 p.m. May 9, 2007 - Carolyn Pritchard
Drug stocks mixed, Dynavax rockets on allergy study 3:40 p.m. Oct. 5, 2006 - Val Brickates Kennedy
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More 4:00 p.m. Jan. 23, 2015 - Seeking Alpha
3 Attractive Biotech Picks For 2015 9:44 a.m. Jan. 23, 2015 - Seeking Alpha
Curis (CRIS) in Focus: Stock Adds 17.5% in Session - Tale of the Tape 8:51 a.m. Jan. 23, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
Curis teams up with Aurigene in cancer 7:50 a.m. Jan. 21, 2015 - Seeking Alpha
Curis (CRIS) Surges: Stock Moves 11.9% Higher - Tale of the Tape 9:11 a.m. Dec. 31, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Curis' (CRIS) CEO, Ali Fattaey on Q3 2014 Results - Earnings Call Transcript 1:58 p.m. Nov. 10, 2014 - Seeking Alpha
Curis (CRIS) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 10, 2014 - Seeking Alpha
10-Q: CURIS INC 8:49 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Following Biotech Stocks After Price Declines Of Greater Than 50% 3:03 p.m. Sept. 25, 2014 - Seeking Alpha
Three Biotechs Ready to Partner Up 9:30 a.m. Sept. 8, 2014 - Barrons.com
Genomic Health Raised to Buy on Better-than-Expected Q2 - Analyst Blog 11:10 a.m. Aug. 14, 2014 - Zacks.com
Emergent BioSolutions Misses on Earnings, Ups Revenue View - Analyst Blog 8:50 a.m. Aug. 11, 2014 - Zacks.com
Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session - Tale of the Tape 8:39 a.m. Aug. 11, 2014 - Zacks.com
Genomic Health Q2 Loss Narrower than Expected, Shares Up - Analyst Blog 8:20 a.m. Aug. 11, 2014 - Zacks.com
Medivation (MDVN) Jumps: Stock Adds 7.5% in Session - Tale of the Tape 7:51 a.m. Aug. 11, 2014 - Zacks.com
10-Q: CURIS INC 2:09 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog 11:00 a.m. Aug. 7, 2014 - Zacks.com
Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog 10:32 a.m. Aug. 7, 2014 - Zacks.com
Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets 6:05 a.m. Jan. 21, 2015 - GlobeNewswire
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:04 a.m. Jan. 13, 2015 - Marketwired
Curis Announces Dosing of First Patient in Phase 1 Trial of CUDC-907 in Patients With Advanced/ Relapsed Solid Tumors 7:02 a.m. Dec. 18, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Curis to Present at Upcoming Investor Conferences 7:01 a.m. Nov. 26, 2014 - GlobeNewswire
Curis to Present at the Stifel 2014 Healthcare Conference 7:01 a.m. Nov. 12, 2014 - GlobeNewswire
Titan Pharmaceuticals Appoints Two New Board Members 7:01 a.m. Nov. 11, 2014 - Marketwired
Curis Reports Third Quarter 2014 Financial Results and Pipeline Update 7:02 a.m. Nov. 10, 2014 - GlobeNewswire
Curis to Release Third Quarter 2014 Financial Results and Hold Conference Call on November 10, 2014 7:01 a.m. Nov. 3, 2014 - GlobeNewswire
Curis Announces Allowance of U.S. Patent Covering Compounds Targeting HDAC and PI3K Activities in a Single Molecule 6:02 a.m. Oct. 28, 2014 - GlobeNewswire
Curis to Present at the 13th Annual BIO Investor Forum 6:01 a.m. Oct. 3, 2014 - GlobeNewswire
Curis Announces CUDC-907 Development Program Advancements 6:01 a.m. Oct. 2, 2014 - GlobeNewswire
Curis to Present at Upcoming Investor Conferences 6:00 a.m. Aug. 27, 2014 - GlobeNewswire
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics 8:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Curis Reports Second Quarter 2014 Financial Results 6:01 a.m. Aug. 7, 2014 - GlobeNewswire
Curis to Release Second Quarter 2014 Financial Results and Hold Conference Call on August 7, 2014 6:02 a.m. July 31, 2014 - GlobeNewswire
Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin 7:10 a.m. July 17, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis 6:01 a.m. June 23, 2014 - GlobeNewswire
Curis to Present at the JMP Securities Healthcare Conference 6:01 a.m. June 18, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼